Physician profile
Nina Safa
NPI 1942357595
$8,986.46
in general payments reported to CMS, 2019-2025
40 companies · $1,300 in 2025
The $1,300 reported for 2025 was more than what 88% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,283 · 2020: $1,671 · 2021: $1,497 · 2022: $1,183 · 2023: $1,078 · 2024: $974 · 2025: $1,300.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,352.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,352.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $2,210.47 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $1,438.09 | 2019-2025 | Vraylar, Synthroid |
| Amgen INC. | $1,022.90 | 2019-2025 | Evenity, Repatha, Prolia |
| Lilly USA, LLC | $699.48 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Boehringer Ingelheim Pharmaceuticals, INC. | $642.60 | 2019-2025 | Jardiance, Spiriva Respimat |
| Allergan, INC. | $282.02 | 2019-2020 | |
| Amarin Pharma, INC. | $256.68 | 2019-2021 | |
| Abbott Laboratories | $210.94 | 2021-2025 | Freestyle Libre 3, Freestyle Libre 2, Eterna |
| Pfizer INC. | $210.91 | 2019-2023 | |
| Kowa Pharmaceuticals America, INC. | $192.42 | 2019-2023 | Seglentis, Livalo |
| Astrazeneca Pharmaceuticals LP | $186.67 | 2019-2025 | Farxiga |
| Astellas Pharma US INC | $158.11 | 2019-2025 | Veozah |
| Phathom Pharmaceuticals, INC. | $152.30 | 2025 | Voquezna |
| Takeda Pharmaceuticals U.S.A., INC. | $132.90 | 2019-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $124.98 | 2022 |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $106.35 | 2019-2021 | |
| Exact Sciences Corporation | $104.89 | 2024-2025 | Cologuard Collection Kit |
| Daiichi Sankyo INC. | $103.62 | 2021-2023 | Injectafer |
| Glaxosmithkline, LLC. | $74.35 | 2019-2025 | Shingrix |
| Medtronic, INC. | $68.37 | 2022-2024 | Minimed 780g |
| Bausch Health US, LLC | $67.10 | 2022 | |
| Mylan Specialty L.P. | $61.92 | 2019-2020 | |
| Genentech USA, INC. | $51.97 | 2019-2021 | |
| Eisai INC. | $50.98 | 2019-2024 | |
| Janssen Pharmaceuticals, INC | $50.33 | 2019-2025 | Spravato |
| Sanofi-Aventis U.S. LLC | $42.35 | 2019-2021 | |
| Currax Pharmaceuticals LLC | $42.26 | 2020-2025 | Contrave |
| Ardelyx, INC. | $38.60 | 2024-2025 | Ibsrela |
| Dexcom, INC. | $32.28 | 2023 | Dexcom G6 Transmitter |
| Dermira, INC. | $28.33 | 2020 | |
| Axsome Therapeutics, INC. | $17.05 | 2023 | Auvelity |
| Strongbridge US INC. | $15.06 | 2019 | |
| Avanir Pharmaceuticals, INC. | $14.71 | 2019 | |
| Almatica Pharma LLC | $14.64 | 2022 | |
| Sanofi Pasteur INC. | $14.23 | 2019 | |
| Althera Pharmaceuticals LLC | $14.18 | 2021 | |
| Amneal Pharmaceuticals LLC | $13.40 | 2021 | |
| Horizon Therapeutics Plc | $13.34 | 2022 | |
| Avion Pharmaceuticals | $12.38 | 2020 | |
| Medicure Pharma INC. | $12.30 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nina Safa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.